US$ 23.54
fda import alert 66-80 glp-1 What Patients Need to Know About the Policy Changes FDA Moves to Close a
Description
1) As you may have heard, the FDA has approved the weight loss drug semaglutide (a GLP-1 agonist) for kids 12 and older with #obesity Good

What's in it
A comprehensive literature search was conducted across the PubMed, Embase, and Google Scholar databases for peer-reviewed articles published from inception through June 15, 2026, focusing on the landmark SURPASS, SURMOUNT, and SUMMIT trial programs, relevant cardiorenal post hoc analyses, emerging body recomposition trials, and real-world cohort-switching protocols

Losing weight doesnt necessarily make you fitter, a new study finds.
